Saturday 17 October 2026 Export SFES’s income statement to Excel — free account

Safeguard Scientifics, Inc.

In the quarter to June 2026, EPS fell 121.7% and free cash flow grew 42.7%, each against the same quarter a year earlier.

0.50 0.03 +6.38%

Follow SFES

Alert me

Market cap: $7.5M
P/E: 0.4×
Fwd P/E: —
Dividend yield: 0.00%
F-score: n/a
Altman Z: n/a
Beneish M: n/a
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

Insider Decisions trades per month

	Dec 25			Mar 26			Jun 26			Sep 26
Buy	—	—	—	—	—	—	—	—	—	—	—	—
Sell	—	—	—	—	—	—	—	—	—	—	—	—

Insider Ownership 26.57%

Capital & Financial Ratios $m

Market Cap 7.54

Revenue —

Net Income 1.73

Free Cash Flow (1.26)

Net Debt (4.84)

Current Ratio 8.07

Debt/Equity 0.00

P/E ratio 0.43

Fwd P/E —

P/S ratio 0.00

P/B ratio 1.34

Past 5Y EPS Growth —

This Y EPS Growth —

Next Y EPS Growth —

Next Y revenue growth —

Next 5Y EPS Growth —

Green and red mark values outside typical ranges. How we judge →

Valuation vs history

P/B against its own 10 years 34.43%

10-year low 10-year high

Dividends

Payout Ratio 0.00

Annual Dividend Rate 0.00

Annual Dividend Yield 0.00%

	total	individual payouts
2022	Powerpack
2021	Powerpack
2020	Powerpack
2019	0.00	1.00
2018	Powerpack
2017	Powerpack

special payouts not included in total or ratios

Assets vs Liabilities $m

	2023	2024	2025	Q'26
Cash	10	7	9	5
Receivables	—	—	—	—
Inventory	—	—	—	—
Other	—	—	—	—
	10	7	9	5

	2023	2024	2025	Q'26
Payables	0	0	0	0
ST’ Debt	—	—	—	—
Other	—	—	—	—
	2	1	1	1

Compound Annual Growth %

	10y	5y	3y
Sales	—	—	—
Cash Flow	0.00%	0.00%	0.00%
Earnings	0.00%	0.00%	0.00%
Book Value	(24.64%)	(28.74%)	(30.61%)

Revenue $m

	Year

Fiscal quarters ending in the months shown.

Operating Cash Flow $m

	Mar	Jun	Sep	Dec	Year
’26	0	(1)	—	—	—
’25	0	(1)	0	0	(2)
’24	(1)	(1)	0	0	(3)
’23	(1)	(1)	0	(1)	(3)
’22	(1)	(1)	(1)	(1)	(3)
’21	(2)	(3)	(1)	(3)	(8)
’20	(3)	(3)	(1)	(1)	(8)

Fiscal quarters ending in the months shown.

Free Cash Flow $m

	Mar	Jun	Sep	Dec	Year
’26	0	(1)	—	—	—
’25	0	(1)	0	0	(2)
’24	(1)	(1)	0	0	(3)
’23	(1)	(1)	0	(1)	(3)
’22	(1)	(1)	(1)	(1)	(3)
’21	(2)	(3)	(1)	(3)	(8)
’20	(3)	(3)	(1)	(1)	(8)

Fiscal quarters ending in the months shown.

EPS $

	Mar	Jun	Sep	Dec	Year
’26	1.10	(0.02)	—	—	—
’25	(0.05)	0.07	0.10	(0.02)	0.10
’24	(0.12)	(0.10)	(0.07)	(0.33)	(0.62)
’23	(0.22)	(0.18)	0.06	(0.27)	(0.61)
’22	(0.40)	0.03	(0.19)	(0.30)	(0.87)
’21	0.84	(0.02)	0.88	(0.51)	1.36
’20	(0.77)	(0.48)	(0.21)	(0.35)	(1.81)

Fiscal quarters ending in the months shown.

Group	Line	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025	2026e
Price, $
Price, $	Low	10.60	10.65	7.98	8.36	4.43	5.95	2.95	0.76	0.40	0.65	Analyst estimates 2026–2028 Powerpack
	High	14.75	14.40	13.95	12.91	11.11	8.98	7.53	3.25	1.14	0.99
People
People	Employees	33	33	—	—	—	—	—	—	—	—
	Revenue/emp, $m	0.00	0.00	—	—	—	—	—	—	—	—
Income, $m
Income, $m	Revenue	—	—	—	—	—	—	—	—	—	—
	Gross margin, %	0.00	0.00	0.00	0.00	0.00	0.00	0.00	—	—	—
	EBT	(22)	(89)	(16)	55	(38)	27	(14)	(10)	(10)	2
	EBT margin, %	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
	Net income	(22)	(89)	(16)	55	(38)	27	(14)	(10)	(10)	2
	Depreciation	2	3	5	5	0	0	0	0	0	0
Per share, $
Per share, $	Revenue	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
	Earnings	(1.09)	(4.34)	(0.76)	2.64	(1.81)	1.36	(0.87)	(0.61)	(0.62)	0.10
	Cash flow	(0.92)	(1.02)	(1.27)	(0.97)	(0.39)	(0.41)	(0.20)	(0.20)	(0.18)	(0.11)
	Capex	(0.02)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.01	0.00
	Free cash flow	(0.94)	(1.02)	(1.27)	(0.97)	(0.39)	(0.41)	(0.20)	(0.20)	(0.17)	(0.11)
	Book value	8.35	4.00	3.26	4.93	3.03	2.55	2.12	1.23	0.59	0.69
	Shares, m	20	20	21	21	21	20	16	16	17	17
Valuation, ×
Valuation, ×	P/E	—	—	—	—	—	—	—	—	—	—
	P/S	—	—	—	—	—	—	—	—	—	—
	P/B	—	—	—	—	—	—	—	—	—	—
	EV/Sales	—	—	—	—	—	—	—	—	—	—
	EV/FCF	—	—	—	—	—	—	—	—	—	—
Cash, $m
Cash, $m	Operating cash flow	(19)	(21)	(26)	(20)	(8)	(8)	(3)	(3)	(3)	(2)
	Capex	0	—	0	—	—	—	—	—	0	—
	Free cash flow	(19)	(21)	(26)	(20)	(8)	(8)	(3)	(3)	(3)	(2)
Balance, $m
Balance, $m	Working capital	27	(12)	14	24	13	29	20	8	6	8
	Total debt	53	86	70	3	2	2	2	—	—	—
	Net debt	22	57	24	(25)	(16)	(25)	(19)	(10)	(7)	(9)
	Shareholders’ equity	170	82	67	102	63	51	35	20	10	12
Returns, %
Returns, %	ROA	(9.11)	(43.39)	(9.70)	43.08	(42.60)	43.89	(31.10)	(32.47)	(60.84)	14.48
	ROIC	(6.09)	(7.72)	(11.59)	(8.14)	(12.51)	(17.33)	(19.55)	(33.95)	(54.53)	(50.98)
	ROE	(12.19)	(70.41)	(21.01)	64.68	(45.70)	47.61	(33.50)	(36.03)	(69.68)	16.14

Negative figures in brackets.

All 10 years →

Fiscal years to Dec 2009 · latest quarter Dec 2009

Charts ten years each

Company	Market cap	P/E	Fwd P/E	Revenue growth (Q)	EPS growth (Q)	FCF growth (Q)	Gross margin (Q)	EBIT margin (Q)	Compare
BCG Binah Capital Group, Inc.	$17.6M	5.1×	28.1×	+12.09% (above 0%: growing)	n/m	+1,679.03% (above 0%: growing)	100.00%	0.91%	Compare
EQS Equus Total Return, Inc.	$13.3M	— (loss-making)	32.9×	−10.92% (below 0%: shrinking)	n/m	+113.19% (above 0%: growing)	100.00%	(266.98%)	Compare
JP Jupai Holdings Limited	$12.1M	— (loss-making)	0.2×	−59.78% (below 0%: shrinking)	n/m	−172.56% (below 0%: shrinking)	33.94%	(132.18%)	Compare
ICMB Investcorp Credit Management BDC, Inc.	$9.9M	— (loss-making)	20.5×	−31.05% (below 0%: shrinking)	n/m	+238.07% (above 0%: growing)	100.00%	59.40%	Compare
BNKK Bonk, Inc.	$9.6M	— (loss-making)	—	+2,491.09% (above 0%: growing)	n/m	−158.27% (below 0%: shrinking)	33.61%	(174.80%)	Compare
SFES Safeguard Scientifics, Inc.	$7.5M	0.4×	—	—	n/m	+42.68% (above 0%: growing)	0.00%	0.00%
TWAV TaoWeave, Inc.	$5.7M	— (loss-making)	12.4×	−11.82% (below 0%: shrinking)	n/m	+107.53% (above 0%: growing)	52.49%	(161.11%)	Compare
ALP Alpha Compute Corp	$5.6M	— (loss-making)	—	—	n/m	+66.68% (above 0%: growing)	0.00%	0.00%	Compare
CWD CaliberCos Inc.	$4.5M	— (loss-making)	— (loss-making)	−17.33% (below 0%: shrinking)	n/m	−126.92% (below 0%: shrinking)	100.00%	(98.97%)	Compare
Median of peers	$9.7M	—	20.5×	−11.82%	—	+87.10%	76.25%	(115.57%)

All 120 Asset Management stocks →